Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Chih Yang

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Medicine|March 11, 2016
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C InfectionWan-Ting Yang, Li-Wei Wu, Tai-Chung Tseng, et al.
Gut|April 26, 2014
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 29, 2024
Fibrosis-4 index stratifies risks of hepatocellular carcinoma in patients with chronic hepatitis CShan-Han Chang, Tung-Hung Su, Ze-Min Ling, et al.
Viruses|November 27, 2021
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in TaiwanChun-Ming Hong, You-Yu Lin, Chun-Jen Liu, et al.
Molecular Therapy. Nucleic Acids|August 20, 2014
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In VivoSu-Ru Lin, Hung-Chih Yang, Yi-Ting Kuo, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversionHung-Chih Yang, Chi-Ling Chen, Yueh-Chi Shen, et al.
Gastroenterology|August 31, 2019
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral LoadTai-Chung Tseng, Chun-Jen Liu, Chen-Yang Hsu, et al.
The Journal of Infectious Diseases|May 13, 2020
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing ChemotherapyWei-Yuan Chang, Yen-Cheng Chiu, Fang-Wei Chiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2015
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibitionTung-Hung Su, Chung-Wai Shiau, Ping Jao, et al.
Scientific Reports|July 2, 2015
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trialChen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Medicine|March 11, 2016
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C InfectionWan-Ting Yang, Li-Wei Wu, Tai-Chung Tseng, et al.
Gut|April 26, 2014
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriersTai-Chung Tseng, Chun-Jen Liu, Hung-Chih Yang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 29, 2024
Fibrosis-4 index stratifies risks of hepatocellular carcinoma in patients with chronic hepatitis CShan-Han Chang, Tung-Hung Su, Ze-Min Ling, et al.
Viruses|November 27, 2021
Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in TaiwanChun-Ming Hong, You-Yu Lin, Chun-Jen Liu, et al.
Molecular Therapy. Nucleic Acids|August 20, 2014
The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In VivoSu-Ru Lin, Hung-Chih Yang, Yi-Ting Kuo, et al.
Hepatology (Baltimore, Md.)|November 1, 2012
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversionHung-Chih Yang, Chi-Ling Chen, Yueh-Chi Shen, et al.
Gastroenterology|August 31, 2019
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral LoadTai-Chung Tseng, Chun-Jen Liu, Chen-Yang Hsu, et al.
The Journal of Infectious Diseases|May 13, 2020
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing ChemotherapyWei-Yuan Chang, Yen-Cheng Chiu, Fang-Wei Chiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2015
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibitionTung-Hung Su, Chung-Wai Shiau, Ping Jao, et al.
Scientific Reports|July 2, 2015
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trialChen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Pageof 15